Document is current
Any future updates will be listed below
-
Authors
Maio, Michele https://orcid.org/0000-0002-0323-6321
Lahn, Michael
Di Giacomo, Anna Maria
Covre, Alessia
Calabrò, Luana
Ibrahim, Ramy
Fox, Bernard
,
Abrignani, Sergio
Paola, Allavena
Anichini, Andrea
Ardizzoni, Andrea
Gregorio, Aversa
Azab, Mohammad
Ballas, Marc
Barberis, Massimo
Bayless, Nicholas L.
Bell, Bryan
Bifarini, Andrea
Blank, Christian
Brodin, Petter
Camerini, Roberto
Ennio, Carbone
Ceccarelli, Michele
Francesca, Colizzi
Connolly, John
Sandra, Coral
Cornelissen, Robin
Eggermont, Alexander
Eid, Joseph
Fajgenbaum, David
Ferretti, Elisabetta
Ferrone, Soldano
Finotello, Francesca
Flaherty, Keith
Ester, Fonsatti
Elisabetta, Fratta
Fridman, Catherine Sautès
Fridman, Wolf H.
Garcia, Patrick
Gherardini, Pier Federico
Goonewardene, Asthika
Hacking, Graham
Heller, Kevin
Hulett, Tyler W.
Michael, Imperiale
Jacobson, Daniel
Janek, Martin
Joho, Stefanie
Keer, Harold
Kleif, Samir
Kotecha, Nikesh
Kotter, Mark
Krogan, Nevan
Lanzavecchia, Antonio
Locatelli, Franco
Lollini, Pier-Luigi
Mantovani, Alberto
Melacarne, Alessia
Melillo, Giovanni
Menden, Michael
Minerva, Daniela
Moretta, Lorenzo
Namouni, Fouad
Natali, Pier Giorgio
Necchi, Andrea
Nisticò, Paola
Cosimo, Paga
Giuseppe, Palmieri
Pardoll, Drew
Paz-Ares, Luis
Plessala, Kimberly
Peters, Solange
Prins, Robert M.
Provendier, Olivier
Rappuoli, Rino
Rescigno, Maria
Ruettinger, Dominik
Seliger, Barbara
Sette, Alessandro
Luca, Sigalotti
Spasic, Marko
Tortora, Giampaolo
Trajanoski, Zlatko
Tunici, Patrizia
Vitale, Chiara
Wigginton, Jon
Yadav, Mahesh
Yu, Haochen
-
Funding
Funding for this research was provided by:
McCann Health Italy
- License Information
-
More Information
Article History
Received: 18 May 2021
Accepted: 18 June 2021
First Online: 23 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: <b>M. Maio</b> reports receipt of honoraria or consultation fees from Roche, MSD, BMS, AZ, Astex, GSK, Amgen, Incyte, Pierre Fabre, Merck Serono, Eli Lilly, Sanofi, Sciclone, Alfasigma, Epigen Therapeutics, and owns stocks in Theravance and Epigen Therapeutics.<b>A.M. Di Giacomo</b> reports receipt honoraria or consultation fees from Incyte, Pierre Fabre, Bristol-Myers Squibb, Merck Sharp Dohme, Sanofi, Novartis and Glaxo Smith Kline.<b>L Calabrò</b> reports receipt honoraria or consultation fees from Bristol-Myers Squibb, Astra Zeneca, Sanofi, Roche and Merck MSD.<b>Alessia Covre</b> owns stocks in Epigen Therapeutics.<b>M. Lahn</b> reports to be an employee of iOnctura SA.<b>B.A. Fox</b> reports Consulting Fees: Turnstone Bio, PrimeVax, UltiVue, AstraZeneca, Boehringer Ingelheim; Contracted Research: Macrogenics, OncoSec, BMS, Akoya, Nanostring, Incyte, Shimadzu, Viralytics/Merck; Cofounder and ownership interest: UbiVac.<b>Ramy Ibrahim</b> reports CMO at bitbio, BoD of bluebird and Surface oncology, SAB member of Harpoon.
